Loading…

Abstract A034: Baseline characteristics of participants enrolled in a randomized controlled trial of a diet and physical activity intervention among Hispanic/Latina breast cancer survivors (in progress)

Background: Cancer survivors are recommended to consume a diet high in fruits and vegetables (F/V), low in energy dense foods, and engage in 150 minutes of moderate-to-vigorous physical activity (MVPA). Hispanic/Latina breast cancer (BC) survivors have higher rates of obesity and lower rates of phys...

Full description

Saved in:
Bibliographic Details
Published in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.A034-A034
Main Authors: Ulanday, Kathleene T., Santiago-Torres, Margarita, Shi, Zaixing, Paul, Rachel, Marin-Chollom, Amanda, Castellano, Marisol, Fuentes, Yanette, Contento, Isobel, Koch, Pam, Gray, Heewon L., Gaffney, Ann O., Hershman, Dawn, Greenlee, Heather
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Cancer survivors are recommended to consume a diet high in fruits and vegetables (F/V), low in energy dense foods, and engage in 150 minutes of moderate-to-vigorous physical activity (MVPA). Hispanic/Latina breast cancer (BC) survivors have higher rates of obesity and lower rates of physical activity compared to non-Hispanic white women. The Mi Vida Saludable (My Healthy Life) trial is testing the effectiveness of a culturally based behavioral intervention on improving and maintaining diet and physical activity changes among Hispanic/Latina BC survivors (R01CA186080, PI: H Greenlee). The primary outcomes are changes, from baseline to 12 months, in daily servings of F/V, total energy density, and physical activity. Methods: Mi Vida Saludable is a 2 × 2 factorial randomized controlled trial conducted in Hispanic/Latina BC survivors living in New York City. The eligibility criteria include: self-identified as Hispanic/Latina female; aged 21 years; diagnosed with stage 0-III BC with no detectable disease; >3 months post-treatment (current use of hormonal therapy allowed); have access to text messaging and the Internet; and available for Saturday intervention classes. Additional eligibility criteria include intake of
ISSN:1055-9965
1538-7755
DOI:10.1158/1538-7755.DISP18-A034